Back to all news
UK Researchers Launch Unbiased AI Testing Platform for Diabetic Retinopathy Screening
Researchers unveiled a new independent platform for fair, large-scale evaluation of commercial AI algorithms detecting diabetic eye disease within the NHS.
Key Details
- 1First real-world head-to-head platform to evaluate commercial AI algorithms for NHS use in detecting diabetic eye disease.
- 2Eight CE marked AI algorithms tested on 1.2 million retinal images from one of the UK’s largest and most diverse screening programs.
- 3Algorithm performance (accuracy) ranged from 83.7% to 98.7% for clinically relevant diabetic eye disease, outperforming or matching human graders.
- 4Algorithms’ accuracy remained consistent across varied ethnic groups; first such assessment at this scale.
- 5AI analyzed images in 240ms–45s compared to up to 20 minutes for humans, vastly improving efficiency.
- 6Funded by NHS Transformation Directorate, The Health Foundation, and Wellcome Trust; study published in The Lancet Digital Health.
Why It Matters
This platform addresses critical gaps in algorithmic fairness, transparency, and efficiency for imaging AI, setting a rigorous new standard for evaluation and deployment in national health systems. Its scalable, unbiased testing approach could serve as a blueprint for clinical AI adoption across radiology and other disease areas.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
AI Deep Learning Model Enhances Echocardiogram RV Assessment and Prognosis
Researchers developed DROID-RV, a deep learning tool that automates right ventricular assessment from echocardiograms, showing strong prognostic links with cardiovascular outcomes.